Obagi Nu-Derm Blender

Država: Singapur

Jezik: engleski

Izvor: HSA (Health Sciences Authority)

Aktivni sastojci:

Hydroquinone

Dostupno od:

NEOASIA (S) PTE LTD

ATC koda:

D11AX11

Doziranje:

4.00%

Farmaceutski oblik:

CREAM

Sastav:

Hydroquinone 4%

Administracija rute:

TOPICAL

Tip recepta:

Prescription Only

Proizveden od:

Pure Tek Corporation

Status autorizacije:

ACTIVE

Datum autorizacije:

2008-08-13

Uputa o lijeku

Obagi Nu-Derm Clear
(Hydroquinone USP, 4%)
Obagi Nu-Derm Blender®
(Hydroquinone USP, 4%)
Rx Only
FOR EXTERNAL USE ONLY
DESCRIPTION
Hydroquinone is 1,4-benzenediol. Hydroquinone
occurs as fine, white needles. The drug is freely solu-
ble in water and in alcohol. Chemically, hydroquinone
is designated as p-dihydroxybenzene; the empirical
formula is C
6
H
6
O
2
; molecular weight is 110.0.
Each gram of Obagi Nu-Derm Blender contains
Hydroquinone USP 40 mg/gm in a base of purified
water, glycerin, cetyl alcohol, polyoxypropylene (2)
myristyl ether propionate, sodium lauryl sulfate,
triethanolamine salicylate, lactic acid, phenyl
trimethicone, tocopheryl acetate, sodium metabisul-
fite, ascorbic acid, methylparaben, saponins, 
edetate disodium, butylated hydroxytoluene, and
propylparaben.
Each gram of Obagi Nu-Derm Clear contains
Hydroquinone USP 40 mg/gm in a base of purified
water, cetyl alcohol, glycerin, sodium lauryl sulfate,
stearyl alcohol, tocopheryl acetate, ascorbic acid,
sodium metabisulfite, lactic acid, saponins, edetate
disodium, methylparaben, butylated hydroxy-
toluene, propylparaben, and butylparaben. 
CLINICAL PHARMACOLOGY
Topical application of hydroquinone produces a
reversible depigmentation of the skin by inhibition
of the enzymatic oxidation of tyrosine to 3, 4-dihy-
droxyphenylalanine (dopa) and suppression of other
melanocyte metabolic processes. 
Exposure to sunlight or ultraviolet light will cause
repigmentation of the bleached areas, which may be
prevented by the use of sunblocking agents.
INDICATIONS AND USAGE
The treatment of hyperpigmented skin condi-
tions such as chloasma, melasma, freckles, senile
lentigines, and other unwanted areas of melanin
hyperpigmentation.
CONTRAINDICATIONS
Prior history of sensitivity or allergic reaction to this
product or any of its ingredients. The safety of topi-
cal hydroquinone use during pregnancy or in chil-
dren (12 years and under) has not been estab-
lished.
WARNINGS
Caution: Hydroquinone is a skin bleaching agent
which may produc

Svojstava lijeka

8.5”
3”
2.125”
2.125”
2.125”
2.125”
Obagi Nu-Derm Clear
(Hydroquinone USP, 4%)
Obagi Nu-Derm Blender
®
(Hydroquinone USP, 4%)
Rx only
FOR EXTERNAL USE ONLY
DESCRIPTION
Hydroquinone is 1, 4-benzenediol. Hydroquinone
occurs as fine, white needles. The drug is freely soluble
in water and in alcohol. Chemically, hydroquinone is
designated as p-dihydroxybenzene; the empirical
formula C
6
H
6
O
2
; molecular weight is 110.0.
Each gram of Obagi Nu-Derm Blender contains
Hydroquinone USP 40 mg/gm is a base of purified
water, glycerin, cetyl alcohol, polyoxypropylene (2)
myristyl ether propionate, sodium lauryl sulfate,
triethanolamine salicylate, lactic acid, phenyl
trimethicone, tocopheryl acetate, sodium metabisulfite,
ascorbic acid, methylparaben, saponins, edetate
disodium, butylated hydroxytoluene, and
propylparaben.
Each gram of Obagi Nu-Derm Clear contains
Hydroquinone USP 40 mg/gm is a base of purified
water, cetyl alcohol, glycerin, sodium lauryl sulfate,
stearyl alcohol, tocopheryl acetate, ascorbic acid,
sodium metabisulfite, lactic acid, saponins, edetate
disodium, methylparaben, butylated hydroxytoluene,
propylparaben, and butylparaben.
CLINICAL PHARMACOLOGY
Topical application of hydroquinone produces a
reversible depigmentation of the skin by inhibition
of the enzymatic oxidation of tyrosine to 3,
4-dihydroxyphenylalanine (dopa) and suppression
of other melanocyte metabolic processes.
Exposure to sunlight or ultraviolet light will cause
repigmentation of the bleached areas, which may be
prevented by the use of sunblocking agents.
INDICATIONS AND USAGE
The treatment of hyperpigmented skin conditions such
as chloasma, melasma, freckles, senile lentigines, and
other unwanted areas of melanin hyperpigmentation.
CONTRAINDICATIONS
Prior history of sensitivity or allergic reaction to this
product or any of its ingredients. The safety of topical
hydroquinone use during pregnancy or in children
(12 years and under) has not been established.
WARNINGS
_Caution:_ Hydroquinone is a skin bleaching agent,
whi